Dan Simionescu to Rats
This is a "connection" page, showing publications Dan Simionescu has written about Rats.
Connection Strength
0.466
-
The acellular myocardial flap: a novel extracellular matrix scaffold enriched with patent microvascular networks and biocompatible cell niches. Tissue Eng Part C Methods. 2013 Jul; 19(7):518-30.
Score: 0.058
-
Regenerative potential of decellularized porcine nucleus pulposus hydrogel scaffolds: stem cell differentiation, matrix remodeling, and biocompatibility studies. Tissue Eng Part A. 2013 Apr; 19(7-8):952-66.
Score: 0.058
-
Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts. Tissue Eng Part A. 2009 Oct; 15(10):2837-51.
Score: 0.046
-
Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A. 2009 Jun; 15(6):1257-68.
Score: 0.045
-
Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 2006 Feb; 27(5):702-13.
Score: 0.035
-
Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
Score: 0.029
-
Pentagalloyl Glucose and Its Functional Role in Vascular Health: Biomechanics and Drug-Delivery Characteristics. Ann Biomed Eng. 2019 Jan; 47(1):39-59.
Score: 0.022
-
Manipulation of cellular spheroid composition and the effects on vascular tissue fusion. Acta Biomater. 2015 Feb; 13:188-98.
Score: 0.017
-
Janus magnetic cellular spheroids for vascular tissue engineering. Biomaterials. 2014 Jan; 35(3):949-60.
Score: 0.015
-
Biological magnetic cellular spheroids as building blocks for tissue engineering. Acta Biomater. 2014 Feb; 10(2):623-9.
Score: 0.015
-
Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol. Biomaterials. 2013 Jan; 34(3):685-95.
Score: 0.014
-
Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease. Osteoporos Int. 2008 May; 19(5):625-35.
Score: 0.010
-
Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol. 2007 Jul; 171(1):116-23.
Score: 0.010
-
Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation. 2007 Apr 03; 115(13):1729-37.
Score: 0.010
-
Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 Jun; 28(18):2861-8.
Score: 0.010
-
In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials. 2007 Jun; 28(18):2830-8.
Score: 0.010
-
Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol. 2007 Jan-Feb; 16(1):29-37.
Score: 0.010
-
Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 2006 Jul; 27(19):3645-51.
Score: 0.009
-
Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006 Feb; 168(2):490-8.
Score: 0.009
-
Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006 Mar; 27(8):1507-18.
Score: 0.009
-
Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
Score: 0.008
-
Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004 Nov 30; 110(22):3480-7.
Score: 0.008
-
Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol. 2004 May-Jun; 13(3):146-55.
Score: 0.008